temozolomide (dose-intense)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for temozolomide (dose-intense), covering 2022-12-20 to 2022-12-20. Get the full timeline:
Most recent: Clinical Trial Update: A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma [Phase 1, Phase 2]